Search - tctmd.com

Displaying 381 - 400 of 797

Sort: Relevancy | Date

News Daily News

孕妇主动脉瓣狭窄患者基本都能存活，但遗留许多并发症

October 11, 2016

News Daily News

Las Mujeres Embarazadas con Estenosis Aórtica Casi Siempre Sobreviven Pero con Complicaciones

October 11, 2016

News Daily News

TAVR 3 年后瓣膜性能持稳，大多数死亡非心脏相关：FRANCE 2 登记表

Caitlin E. Cox

October 04, 2016

News Daily News

Registro FRANCE 2: 3 Años Después de una TAVR, el Rendimiento de la Válvula se Mantiene y casi Toda la Mortalidad es No Cardíaca

Caitlin E. Cox

October 04, 2016

News Industry News

Medtronic Avalus(TM) Surgical Aortic Valve Shows Positive Outcomes in One-Year Clinical Trial Results

October 04, 2016

News Daily News

At 3 Years Post-TAVR, Valve Performance Holds Steady and Most Mortality Is Noncardiac: FRANCE 2 Registry

Caitlin E. Cox

October 04, 2016

MitraClip Feasible, Safe, and Produces Promising Early Results in Tricuspid Regurgitation

Shelley Wood

September 19, 2016

News Daily News

Elderly Asymptomatic Patients With Severe AS Are Often Treated Too Late

L.A. McKeown

September 16, 2016

News Conference News ESC 2016

ICDs Do Not Reduce Mortality in Patients With HF Not Caused by Coronary Artery Disease: DANISH

Michael O'Riordan

August 28, 2016

News Industry News

EDWARDS INTUITY Elite Rapid Deployment Valve Receives FDA Approval

August 15, 2016

News Daily News

MAC 全球登记首次发表的报告强调了经导管二尖瓣置换的风险和机遇

Shelley Wood

July 11, 2016

News Daily News

First Published Report From MAC Global Registry Highlights Risks, Opportunities for Transcatheter Mitral Valve Replacement

Shelley Wood

July 11, 2016

News Daily News

El 1er Informe Publicado del Registro MAC Global Refleja los Riesgos y Oportunidades de la Sustitución de la Válvula Mitral Transcatéter

Shelley Wood

July 11, 2016

News Industry News

Capricor Therapeutics Reports Positive 12-Month Data from the DYNAMIC Clinical Trial

June 17, 2016

News Daily News

利拉鲁肽超越 FDA 安全预期，可降低心血管疾病的死亡率：LEADER

Michael O'Riordan

June 14, 2016

News Daily News

MitraClip for Obstructive Hypertrophic Cardiomyopathy? Small Series Raises Hopes

Shelley Wood

June 14, 2016

News Daily News

Liraglutide Leaps Over FDA Safety Hurdle, With Cardiovascular Mortality Reduction to Boot: LEADER

Michael O'Riordan

June 14, 2016

News Daily News

Estudio LEADER: Liraglutide se Salta la Valla de Seguridad de la FDA al Confirmarse un Descenso de la Mortalidad Cardiovascular

Michael O'Riordan

June 14, 2016

News Conference News EuroPCR 2016

‘Europe Isn’t Waiting’: MitraClip Moves Into New Niches, Big and Small

Shelley Wood

May 26, 2016

News Conference News EuroPCR 2016

Studies Highlight Permanent Pacemaker Rates Among New-Generation TAVR Devices

Michael O'Riordan

May 23, 2016

Advertisement

孕妇主动脉瓣狭窄患者基本都能存活，但遗留许多并发症

Las Mujeres Embarazadas con Estenosis Aórtica Casi Siempre Sobreviven Pero con Complicaciones

TAVR 3 年后瓣膜性能持稳，大多数死亡非心脏相关：FRANCE 2 登记表

Registro FRANCE 2: 3 Años Después de una TAVR, el Rendimiento de la Válvula se Mantiene y casi Toda la Mortalidad es No Cardíaca

Medtronic Avalus(TM) Surgical Aortic Valve Shows Positive Outcomes in One-Year Clinical Trial Results

At 3 Years Post-TAVR, Valve Performance Holds Steady and Most Mortality Is Noncardiac: FRANCE 2 Registry

MitraClip Feasible, Safe, and Produces Promising Early Results in Tricuspid Regurgitation

Elderly Asymptomatic Patients With Severe AS Are Often Treated Too Late

ICDs Do Not Reduce Mortality in Patients With HF Not Caused by Coronary Artery Disease: DANISH

EDWARDS INTUITY Elite Rapid Deployment Valve Receives FDA Approval

MAC 全球登记首次发表的报告强调了经导管二尖瓣置换的风险和机遇

First Published Report From MAC Global Registry Highlights Risks, Opportunities for Transcatheter Mitral Valve Replacement

El 1er Informe Publicado del Registro MAC Global Refleja los Riesgos y Oportunidades de la Sustitución de la Válvula Mitral Transcatéter

Capricor Therapeutics Reports Positive 12-Month Data from the DYNAMIC Clinical Trial

利拉鲁肽超越 FDA 安全预期，可降低心血管疾病的死亡率：LEADER

MitraClip for Obstructive Hypertrophic Cardiomyopathy? Small Series Raises Hopes

Liraglutide Leaps Over FDA Safety Hurdle, With Cardiovascular Mortality Reduction to Boot: LEADER

Estudio LEADER: Liraglutide se Salta la Valla de Seguridad de la FDA al Confirmarse un Descenso de la Mortalidad Cardiovascular

‘Europe Isn’t Waiting’: MitraClip Moves Into New Niches, Big and Small

Studies Highlight Permanent Pacemaker Rates Among New-Generation TAVR Devices

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content